Company profile for NTC

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

NTC Srl is an Italian pharmaceutical company founded in 1997 active in the field of niche generics, OTC, medical devices, innovative food supplements.The international presence of NTC covers more than 50 countries and operates through two business models:- Business to Business where NTC provides key-on-hands products including regulatory support;- Business to Consumer active for specific therapeutic areas in selected countries...
NTC Srl is an Italian pharmaceutical company founded in 1997 active in the field of niche generics, OTC, medical devices, innovative food supplements.The international presence of NTC covers more than 50 countries and operates through two business models:- Business to Business where NTC provides key-on-hands products including regulatory support;- Business to Consumer active for specific therapeutic areas in selected countries.NTC activity involves several therapeutic areas: opthalmic; gynaecology, gastroenterology, dermatology, ent (ear,nose,throat) focusing on product presentation such as oral dispersable films, transdermal patches, etc.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Italy
Address
Address
Via dei Gracchi 35
Telephone
Telephone
02 438 5041
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/five-year-pharmacovigilance-study-by-ntc-confirms-safety-of-fixed-dose-eye-drops-for-post-cataract-surgery-302502272.html

PR NEWSWIRE
17 Jul 2025

https://www.indianpharmapost.com/news/ntc-presents-positive-results-from-phase-ii-mirakle-study-evaluating-an-innovative-drug-for-bacterial-conjunctivitis-16510

INDPHARMAPOST
07 Dec 2024

https://www.prnewswire.com/news-releases/ntc-presents-positive-results-from-phase-ii-mirakle-study-evaluating-an-innovative-drug-for-bacterial-conjunctivitis-302321325.html

PR NEWSWIRE
05 Dec 2024

https://www.prnewswire.com/news-releases/ntc-launches-imperial-the-new-eye-drops-product-line-on-the-patients-side-302263058.html

PR NEWSWIRE
07 Oct 2024

https://www.prnewswire.com/news-releases/ntc-gives-long-term-consistency-to-its-ophtha-portfolio-with-another-mdr-ce-certificate-approval-302154587.html

PR NEWSWIRE
30 May 2024

https://www.prnewswire.com/news-releases/ntc-und-aspen-geben-positives-sahpra-ergebnis-fur-die-fest-dosierte-kombination-aus-levofloxacin-und-dexamethason-augentropfen-in-mehreren-dosen-bekannt-809733682.html

PRNEWSWIRE
24 Nov 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty